Biomarkers · Chemical
PrEP hCG, Total, Quantitative
- LOINC codes
- 21198-7
- Tests that measure PrEP hCG, Total, Quantitative
- Quest Diagnostics 13
Ranges
Each lab publishes a reference range for the population groups it tests, usually the middle 95% of results. These intervals describe that population, not an optimal or healthy target. How ranges differ
Quest Diagnostics, PrEP hCG, Total, Quantitative 13696
| Population | Interval |
|---|---|
| Male | <5 mIU/mL |
| Postmenopausal | <10 mIU/mL |
| Nonpregnant or Premenopausal | <5 mIU/mL |
| Female | Not stated |
Quest Diagnostics, hCG with Gestational Table 19485
| Population | Interval |
|---|---|
| (mIU/mL), <1 Week | 5-50 |
| (mIU/mL), 1-2 Weeks | 50-500 |
| (mIU/mL), 2-3 Weeks | 100-5000 |
| (mIU/mL), 3-4 Weeks | 500-10000 |
| (mIU/mL), 4-5 Weeks | 1000-50000 |
| (mIU/mL), 5-6 Weeks | 10000-100000 |
| (mIU/mL), 6-8 Weeks | 15000-200000 |
| (mIU/mL), 2-3 Months | 10000-100000 |
| Gestational Age | Expected hCG Values (mIU/mL) |
Quest Diagnostics, hCG, Total, Quantitative 8396
| Population | Interval |
|---|---|
| Male | <5 mIU/mL |
| Postmenopausal | <10 mIU/mL |
| Non-pregnant or Premenopausal | <5 mIU/mL |
| Female | Not stated |
Tests
Check the catalog code, specimen, method and preparation for every test that measures PrEP hCG, Total, Quantitative. Select up to five tests to compare them side by side.
Quest Diagnostics 13 tests
Single-analyte tests
hCG with Gestational Table 19485
Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Immunoassay (IA)
hCG, Total with HAMA Treatment 19720
Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Immunoassay (IA)
- Reference notes
- hCG, Total, Quantitative HAMA Treated See below hCG, Total, Quantitative Untreated Males: <5 mIU/mL Females: Non-pregnant or Premenopausal: <5 mIU/mL Postmenopausal: <10 mIU/mL
hCG, Total, Quantitative 8396
Serum · Fasting not stated · Turnaround Set up: Sun-Fri; Report available: 3 days
Quest Diagnostics catalog pageMethod and collection
- Method
- Immunoassay (IA)
PrEP hCG, Total, Quantitative 13696
Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Immunoassay (IA)
Panels that include this biomarker
First Trimester Screen, hCG 16145
2 analytes · Serum · Fasting not stated · Turnaround Set up: Mon-Fri
Quest Diagnostics catalog pageMethod and collection
- Method
- Calculation (CALC) • Chemiluminescence (CL) • Immunoassay (IA)
Sequential Integrated Screen, Part 1 16131
2 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Chemiluminescence (CL) • Immunoassay (IA)
- Collection
- Collect between 10.0 weeks to 13.9 weeks. Must complete patient demographic information using the Maternal Serum Screen Requisition. Additional information: NT measurement, when provided by the physician, will be used for additional interpretation.
- Reference notes
- See Laboratory Report
Stepwise, Part 1 16463
2 analytes · Serum · Fasting not stated · Turnaround Set up: Mon-Sat
Quest Diagnostics catalog pageMethod and collection
- Method
- Chemiluminescence (CL) • Immunoassay (IA)
- Reference notes
- See Laboratory Report
Quad Screen 30294
4 analytes · Serum · Fasting not stated · Turnaround Set up: Mon-Fri (Day shift); Report available: 4 days
Quest Diagnostics catalog pageMethod and collection
- Method
- Immunoassay (IA)
- Collection
- For manual orders use "Maternal Serum Screen Requisition" The Quad test in pregnant women should be performed between 14.0 and 22.9 weeks gestational age, although the optimal period is 15.0-16.9 weeks. This time frame allows sufficient opportunity for further diagnostic studies if the initial Quad Screen test results are abnormal. Specimens submitted before 14.0 weeks or after 22.9 weeks gestation cannot be properly evaluated for open neural tube defects, Down Syndrome or Trisomy 18. The Maternal Serum Screen Requisition designed to obtain patient data and the patient's informed consent must be utilized when ordering the Quad Screen test. Because the Quad Screen test results are influenced by certain patient characteristics, the following data must be provided with the specimen in order to permit accurate interpretation of results: date of collection, patient's (maternal) date of birth, patient's estimated date of delivery, patient's weight, patient's race, patient's diabetic status (is patient insulin dependent prior to pregnancy), number of fetuses, and whether this is a repeat sample.
- Reference notes
- See Laboratory Report
Sequential Integrated Screen, Part 2 16133
4 analytes · Serum · Fasting not stated
Quest Diagnostics catalog pageMethod and collection
- Method
- Chemiluminescence (CL) • Immunoassay (IA)
- Collection
- Collect between 14.0 to 22 6/7 weeks. Maternal date of birth (mm/dd/yy), Estimated Date of Delivery by US/LMP/PE, weight, race, insulin-dependent diabetes status, repeat sample (Y/N), number of fetuses, and neural tube defect history must be provided for interpretation of results. Must complete patient demographic information using the Maternal Serum Screen Requisition.
- Reference notes
- See Laboratory Report
0 of 5 tests selected
Pick one moreSources
Quest Diagnostics test catalog
13 tests: codes, specimens, methods, preparation and reference intervals.
LOINC 21198-7
Regenstrief Institute codes that identify the same result across labs.
Search ClinicalTrials.gov for PrEP hCG, Total, Quantitative
Registered studies that measure PrEP hCG, Total, Quantitative, on the U.S. National Library of Medicine registry.
Verify these ranges and sources
We compile this page from named laboratory catalogs, guidelines and studies. Labs calculate reference intervals from the people they test, for one assay method and one population group, so an interval describes that population rather than an optimal target.
Interpret your own results with a licensed clinician, or track your lab history and health goals in Aumnivida.
Spotted an error? Email hello@biomarkerlens.com with the page URL and the primary source that corrects the entry.